This federal contract award, valued at $16,662.16, was issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS, a critical medical commodity used in the prevention and treatment of rabies.
The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Generated 3/7/25, 10:02 AM